EUVIMEDEUVIMED entdecken
Metaanalyse

Reevaluating the causal link between liver fat and hyperglycaemia

Zhaoqian Xu, Qi Huang, Xinlei Zhang, Song Wang, Yingying Luo, Feng Liu, Linong Ji iD, Xiantong Zou iD

Diabetes, Obesity and Metabolism · 2026

DOI: 10.1111/dom.70178 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Diabetes, Obesity and Metabolism, 2026. Verfasst von Zhaoqian Xu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing, China. Hauptthemen laut MEDLINE: Hyperglycemia, Liver, Fatty Liver, Diabetes Mellitus, Type 2. Die Arbeit nennt 41 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Nova Cross Program of Science and Technology, Peking University People's Hospital Research and Development Funds.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Given the proposed role of liver fat in diabetes, this study examined its potential causal relationship with glycaemic traits. Materials and Methods A two‐sample Mendelian randomisation (MR) analysis using genome‐wide association study (GWAS) data from 37 358 individuals was conducted to evaluate the causal effect of liver fat on fasting glucose level, HbA1c level, postprandial glucose level, fasting insulin level, and homeostatic model assessment of insulin resistance (HOMA‐IR). A meta‐analysis of randomised controlled trials (RCTs) examining drugs that target hepatic steatosis and their effects on glycaemic traits was subsequently performed.

Results

MR analysis revealed no causal effect of liver fat content on the following glycaemic traits: fasting glucose level ( β = −0.006; p = 0.827), HbA1c level ( β = −0.009; p = 0.366), postprandial glucose level ( β = −0.063; p = 0.257), fasting insulin level ( β = 0.010; p = 0.691), and HOMA‐IR ( β = 0.001; p = 0.965). In 13 RCTs of liver fat‐targeted drugs ( n = 2482), no significant differences were observed in the changes in fasting blood glucose (SMD: −0.09, 95% CI: −0.18 to 0.01) or HbA1c levels (SMD: −0.02, 95% CI: −0.12 to 0.07) between drug‐treated patients and controls. Meta‐regression analysis revealed no statistically significant linear relationship between liver fat reduction and changes in fasting blood glucose or HbA1c levels.

Conclusion

The absence of a causal relationship between hepatic steatosis and glycaemic traits suggests that hyperglycaemia in metabolic dysfunction‐associated steatotic liver disease may involve additional mechanisms beyond liver fat accumulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperglycemiaLiverFatty LiverDiabetes Mellitus, Type 2HumansBlood GlucoseMendelian Randomization AnalysisInsulin ResistanceGlycated HemoglobinGenome-Wide Association StudyRandomized Controlled Trials as TopicFastingPostprandial PeriodInsulinMaleFemale

Stichwörter der Autor:innen

fatty liverglycaemic controlmetabolic dysfunction‐associated steatohepatitis (MASH)metabolic dysfunction‐associated steatotic liver disease (MASLD)type 2 diabetes

Substanzen

Blood GlucoseGlycated HemoglobinInsulinhemoglobin A1c protein, human

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, Peking University People's Hospital, Peking University Diabetes Center, Beijing, China.
  • Department of Hepatology, Peking University People's Hospital, Peking University Hepatology Institute, Beijing Key Laboratory of Hepatitis C and Immunotherapy for Liver Diseases, Beijing, China.

ORCID-Profile: Linong Ji, Xiantong Zou

Förderung

  • National Natural Science Foundation of China
  • Beijing Nova Cross Program of Science and Technology
  • Peking University People's Hospital Research and Development Funds

Zitieren

APA

Xu, Z., Huang, Q., Zhang, X., Wang, S., Luo, Y., Liu, F., Ji, L., & Zou, X. (2026). Reevaluating the causal link between liver fat and hyperglycaemia. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.70178

Vancouver

Xu Z, Huang Q, Zhang X, Wang S, Luo Y, Liu F, et al. Reevaluating the causal link between liver fat and hyperglycaemia. Diabetes, Obesity and Metabolism. 2026. doi:10.1111/dom.70178

BibTeX
@article{Xu2026,
  author = {Xu, Zhaoqian and Huang, Qi and Zhang, Xinlei and Wang, Song and Luo, Yingying and Liu, Feng and Ji, Linong and Zou, Xiantong},
  title = {Reevaluating the causal link between liver fat and hyperglycaemia},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  doi = {10.1111/dom.70178}
}
Kostenlos starten →